Back to Invesco Ltd. Invesco Ltd.

ELVELV
Showing 8 of 28 quarters

Position history for Invesco Ltd.Invesco Ltd.'s holdings in ELEVANCE HEALTH INC FORMERLY

Yes. Invesco holds 4,234,231 shares of ELV (Elevance Health), worth $1.6B, as of its Q2 2026 13F filing. It reduced the position by 583,179 shares (-12.1%) from Q1 2026. Invesco has held ELV in every 13F on record since Q3 2019, 28 quarterly filings. ELV is 0.1% of Invesco's reported 13F portfolio.

Current Value

$1.6B

Current Shares

4.2M

Total Value Change

+$399M

Total Shares Change

+1.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
4.2M
-12.1%
$1.6B0.1%$385.05
0
2026-Q1
Increased
4.8M
+23.4%
$1.4B0.1%$290.30
46
2025-Q4
Increased
3.9M
+50.3%
$1.4B0.1%$345.49
53
2025-Q3
Increased
2.6M
+22.9%
$839.3M0.1%$316.82
46
2025-Q2
Decreased
2.1M
-0.1%
$821.9M0.1%$379.31
0
2025-Q1
Increased
2.1M
+1.2%
$920.5M0.2%$422.30
38
2024-Q4
Decreased
2.1M
-12.2%
$771.5M0.1%$356.67
0
2024-Q3
Increased
2.4M
+30.1%
$1.2B0.2%$500.71
48

Other major holders of ELV: BlackRock Finance, Inc., VANGUARD GROUP INC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used